News | September 02, 2023
Jupiter Life Line Hospitals’ IPO to open on Sept. 6
Sets price band at ?695 to ?735 per Equity Share
Sets price band at ?695 to ?735 per Equity Share
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Aims to build the largest connected healthcare ecosystem in India
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated
